Cargando…
Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhage
The purpose of this study was to evaluate the 1-year visual outcomes of patients treated with intravitreal aflibercept (IVA) or brolucizumab (IVBr) for submacular hemorrhage (SMH) secondary to neovascular age-related macular degeneration (AMD). We retrospectively studied 62 treatment-naïve eyes with...
Autores principales: | Maruyama-Inoue, Maiko, Kitajima, Yoko, Yanagi, Yasuo, Inoue, Tatsuya, Kadonosono, Kazuaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081992/ https://www.ncbi.nlm.nih.gov/pubmed/37029159 http://dx.doi.org/10.1038/s41598-023-32874-0 |
Ejemplares similares
-
Incidence of elevated intraocular pressure after intravitreal injection in Japanese patients with age-related macular degeneration
por: Maruyama-Inoue, Maiko, et al.
Publicado: (2021) -
One-year outcomes of intravitreal brolucizumab injections in patients with polypoidal choroidal vasculopathy
por: Ito, Arisa, et al.
Publicado: (2022) -
Sensitivity and specificity of high-resolution wide field fundus imaging for detecting neovascular age-related macular degeneration
por: Maruyama-Inoue, Maiko, et al.
Publicado: (2020) -
Hyperreflective material in patients with non-neovascular pachychoroid disease
por: Maruyama-Inoue, Maiko, et al.
Publicado: (2023) -
Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life
por: Inoue, Maiko, et al.
Publicado: (2014)